NIH-funded research P01 program project

Nasal microbiome and how it shapes defense against flu and its spread

Official title: Contributions of the Nasal Microbiome to Host Defense and Influenza Transmission - Project 2

Funded at Duke University · NIH-11451343 · Data updated 2026-11-12

A Duke-led project looks at how the nasal microbes influence how our bodies defend against influenza and how easily the virus spreads.

More Influenza research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 14, 2026
Project endJuly 31, 2031
Funding year2026
Award (this year)$626,156
NIH project number1P01AI202707-01
Project IDNIH-11451343 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with or at risk for influenza, and those who have been exposed to infected individuals, may contribute samples or data.

Less likely to help

People without influenza exposure or without participation in nasal microbiome studies may not directly benefit.

What this research studies

This project investigates how communities of bacteria and other microbes in the nose and throat interact with our immune system to affect flu infection risk and transmission. By studying human samples from infected and non-infected individuals, researchers will map microbiome-host interactions that may change susceptibility and contagiousness. The work combines profiling of the nasal microbiome with immune system measurements to understand these relationships over time. The goal is to pinpoint microbial and immune factors that could be targeted to reduce flu risk and spread.

Why it matters

Potential benefit: If successful, findings could lead to new strategies to strengthen mucosal defense against flu and limit transmission.

How similar studies have gone: Previous studies show microbiome-immune interactions can influence infection susceptibility, but larger, more detailed studies are needed.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Moody, Michael Anthony — Duke University
  • Study coordinator: Moody, Michael Anthony

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.